Skip to main content

Advertisement

SpringerLink
Log in

Clinical significance of atrial fibrillation in hypertrophic cardiomyopathy

  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Atrial fibrillation (AF) is the most common sustained arrhythmia in patients with hypertrophic cardiomyopathy (HCM), and it bears numerous pathophysiologic consequences that potentially affect patient outcome and symptoms. However, studies regarding the impact of AF on the long-term prognosis of HCM patients have been limited in number, with sometimes conflicting results. Recently, studies on community-based patient populations showed that AF is associated with long-term clinical deterioration, embolic complications, and increased cardiovascular mortality due to heart failure and stroke. The consequences of AF on the long-term prognosis of HCM patients are not uniformly unfavorable, however, and in about one third of patients the arrhythmia is compatible with an uneventful course.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. MaronBJ, Bonow RO, Cannon RO, et al.: Hypertrophic cardiomyopathy: interrelation of clinical manifestations, pathophysiology, and therapy. N Engl J Med 1987, 316:780–789, 844–852.

    Article  Google Scholar 

  2. Spirito P, Seidman CE, McKenna WJ, Maron BJ: The management of hypertrophic cardiomyopathy. N Engl J Med 1997, 336:775–785.

    Article  PubMed  CAS  Google Scholar 

  3. Maron BJ: Hypertrophic cardiomyopathy. Lancet 1997, 350:127–133.

    Article  PubMed  CAS  Google Scholar 

  4. Maron BJ, Cecchi F, McKenna WJ: Risk factors and current status of risk stratification profiles for sudden cardiac death in patients with hypertrophic cardiomyopathy. Br Heart J 1994, 72(Suppl):S13-S18.

    PubMed  CAS  Google Scholar 

  5. McKenna WJ, Camm AJ: Sudden death in hypertrophic cardiomyopathy: assessment of patients at high risk. Circulation 1989, 80:1489–1492.

    PubMed  CAS  Google Scholar 

  6. Spirito P, Chiarella F, Carratino L, et al.: Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med 1989, 320:749–755.

    Article  PubMed  CAS  Google Scholar 

  7. Maron BJ, Olivotto I, Spirito P, et al.: Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large nonreferral based patient population. Circulation 2000, 102:858–864. This study shows that cardioembolic stroke occurring in the context of atrial fibrillation is an important cause of death in HCM patients.

    PubMed  CAS  Google Scholar 

  8. Kofflard MJ, Waldstein DJ, Vos J, ten Cate FJ: Prognosis in hypertrophic cardiomyopathy: long-term follow-up in a large, unselected outpatient population. Am J Cardiol 1993, 72:939–943.

    Article  PubMed  CAS  Google Scholar 

  9. Cannan CR, Reeder GS, Bailey KR, et al.: Natural history of hypertrophic cardiomyopathy: a population-based study, 1976 through 1990. Circulation 1995, 92:2488–2495.

    PubMed  CAS  Google Scholar 

  10. Cecchi F, Olivotto I, Montereggi A, et al.: Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected population. J Am Coll Cardiol 1995, 26:1529–1536.

    Article  PubMed  CAS  Google Scholar 

  11. Maron BJ, Casey SA, Poliac L, et al.: Clinical course of hypertrophic cardiomyopathy in a Regional United States Cohort. JAMA 1999, 281:650–655. In this paper, describing the relatively benign prognosis of HCM in a nonreferral population, atrial fibrillation was shown to represent an important predictor of adverse outcome.

    Article  PubMed  CAS  Google Scholar 

  12. McKenna WJ: Arrhythmia and prognosis in hypertrophic cardiomyopathy. Eur Heart J 1983, 4(Suppl F):225–234.

    PubMed  Google Scholar 

  13. Glancy DL, O’Brien KP, Gold HK, Epstein SE: Atrial fibrillation in patients with idiopathic hypertrophic subaortic stenosis. Br Heart J 1970, 32:652–659.

    PubMed  CAS  Google Scholar 

  14. Robinson KC, Frenneaux MP, Stockins B, et al.: Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. J Am Coll Cardiol 1990, 15:1279–1285.

    Article  PubMed  CAS  Google Scholar 

  15. Greenspan AM: Hypertrophic cardiomyopathy and atrial fibrillation: a change of perspective. J Am Coll Cardiol 1990, 15:1286–1287.

    Article  PubMed  CAS  Google Scholar 

  16. Stafford WJ, Trohman RG, Bilsker M, et al.: Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy. J Am Coll Cardiol 1986, 7:701–704.

    Article  PubMed  CAS  Google Scholar 

  17. Stewart JT, McKenna WJ: Arrhythmias in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol 1991, 2:516–524.

    Article  Google Scholar 

  18. Furlan AJ, Craciun AR, Raju NR, Hart N: Cerebrovascular complications associated with idiopathic hypertrophic subaortic stenosis. Stroke 1984, 15:282–284.

    PubMed  CAS  Google Scholar 

  19. Suzuki M, Hirayama T, Marumoto K, et al.: Paroxysmal atrial fibrillation as a cause of potentially lethal ventricular arrhythmia with myocardial ischemia in hypertrophic cardiomyopathy -a case report. Angiology 1998, 49:653–657.

    Article  PubMed  CAS  Google Scholar 

  20. Higashikawa M, Nakamuri Y, Yoshida M, Kinoshita M: Incidence of ischemic strokes in hypertrophic cardiomyopathy is markedly increased if complicated by atrial fibrillation. Jpn Circ J 1997, 61:673–681.

    Article  PubMed  CAS  Google Scholar 

  21. Shigematsu Y, Hamada M, Mukai M, et al.: Mechanism of atrial fibrillation and increased incidence of thromboembolism in patients with hypertrophic cardiomyopathy. Jpn Circ J 1995, 59:329–336.

    PubMed  CAS  Google Scholar 

  22. Kogure S, Yamamoto Y, Yomono S, et al.: High risk of systemic embolism in hypertrophic cardiomyopathy. Jpn Heart J 1986, 27:475–480.

    PubMed  CAS  Google Scholar 

  23. Brembilla-Perrot B, Terrier de La Chaise A, Beurrier D: Paroxysmal atrial fibrillation: main cause of syncope in hypertrophic cardiomyopathy. Arch Mal Coeur Vaiss 1993, 86:1573–1578.

    PubMed  CAS  Google Scholar 

  24. Olivotto I, Cecchi F, Santoro G, et al.: Atrial fibrillation is an important determinant of outcome in patients with hypertrophic cardiomyopathy [abstract]: 72nd Session of the American Heart Association. Circulation 1999, 100:I76.

    Google Scholar 

  25. Maron BJ, Spirito P, Green KJ, et al.: Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1987, 10:733–742.

    Article  PubMed  CAS  Google Scholar 

  26. Bonow RO, Frederick TM, Bacharach SL, et al.: Atrial systole and left ventricular filling in patients with hypertrophic cardiomyopathy: effect of verapamil. Am J Cardiol 1983, 51:1386–1391.

    Article  PubMed  CAS  Google Scholar 

  27. Losi MA, Betocchi S, Grimaldi M: Heterogeneity of left ventricular filling dynamics in hypertrophic cardiomyopathy. Am J Cardiol 1994, 73:987–990.

    Article  PubMed  CAS  Google Scholar 

  28. Spirito P, Lakatos E, Maron BJ: Degree of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy and chronic atrial fibrillation. Am J Cardiol 1992, 69:1217–1222.

    Article  PubMed  CAS  Google Scholar 

  29. Spirito P, Maron BJ, Bonow RO, Epstein SE: Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in patients with hypertrophic cardiornyopathy. Am J Cardiol 1987, 60:123–129.

    Article  PubMed  CAS  Google Scholar 

  30. Panza JA, Petrone RK, Fananapazir L, Maron BJ: Utility of continuous wave Doppler in noninvasive assessment of the left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1992, 19:91–99.

    Article  PubMed  CAS  Google Scholar 

  31. Wigle ED, Adelman AG, Auger P, Marquis Y: Mitral regurgitation in muscular subaortic stenosis. Am J Cardiol 1969, 24:698–706.

    Article  PubMed  CAS  Google Scholar 

  32. Petrone RK, Klues HG, Panza JA, et al.: Significance of the occurrence of mitral valve prolapse in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1992, 20:55–61.

    Article  PubMed  CAS  Google Scholar 

  33. Gruver EJ, Fatkin D, Dodds GA, et al.: Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation. Am J Cardiol 1999, 83:13H-18H. This interesting report suggests a pathophysiologic pathway leading from a specific genetic mutation to the onset of atrial fibrillation in an HCM family.

    Article  PubMed  CAS  Google Scholar 

  34. Cecchi F, Montereggi A, Olivotto I, et al.: Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by Signal-averaged P-wave. Heart 1997, 78:44–49.

    PubMed  CAS  Google Scholar 

  35. Cannon RO, Rosing DR, Maron BJ, et al.: Myocardial ischemia in hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation 1985, 71:234–243.

    PubMed  Google Scholar 

  36. O’Gara PT, Bonow RO, Maron BJ, et al.: Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography. Circulation 1987, 76:1214–1223.

    PubMed  CAS  Google Scholar 

  37. Di Pasquale G, Andreoli A, Lusa AM, et al.: Cerebral embolic risk in hypertrophic cardiomyopathy. In Advances in Cardiomyopathies. Edited by Baroldi G, Camerini F, Goodwin J. Milano: Springer Verlag; 1990:91–96.

    Google Scholar 

  38. Frenneaux MP, Counihan PJ, Caforio ALP, et al.: Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. Circulation 1991, 82:1995–2002.

    Google Scholar 

  39. Levy S, Breithardt G, Campbell RW, et al.: Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J 1998, 19:1294–1320. A comprehensive review ranging from epidemiology to the stateof- the-art managenent of atrial fibrillation.

    Article  PubMed  CAS  Google Scholar 

  40. Cecchi F, Maron BJ, Epstein SE: Long-term outcome of patients with hypertrophic cardiomyopahy successfully resuscitated after cardiac arrest. J Am Coll Cardiol 1989, 13:1283–1288.

    Article  PubMed  CAS  Google Scholar 

  41. Benjamin EJ, Wolf PA, D’Agostino RB, et al.: Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998, 98:946–952. A seminal paper revealing the substantial impact of atrial fibrillation on prognosis in the general population.

    PubMed  CAS  Google Scholar 

  42. Maron BJ, Spirito P: Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history. Am J Cardiol 1993, 72:970–972.

    Article  PubMed  CAS  Google Scholar 

  43. Maron BJ, Spirito P, Bellone P, et al.: Prevalence and clinical profile of stroke and other peripheral embolizations in patients with hypertrophic cardiomyopathy: a United States and Italy cooperative study [abstract]. J Am Coll Cardiol 1998, 31(Suppl A):26A.

    Article  Google Scholar 

  44. Middlekauff HR, Stevenson WG, Stevenson LW: Prognostic significance of atrial fibrillation in advanced heart failure: a study of 390 patients. Circulation 1991, 84:40–48

    PubMed  CAS  Google Scholar 

  45. Cameron A, Schwartz MJ, Kronmal RA, Kosinski AS: Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry). Am J Cardiol 1988, 61:714–717.

    Article  PubMed  CAS  Google Scholar 

  46. Cecchi F, Olivotto I, Montereggi A, et al.: Prognostic value of nonsustained ventricular tachycardia and efficacy of amiodarone treatment in an unselected patient population with hypertrophic cardiomyopathy. Heart 1998, 79:331–336.

    PubMed  CAS  Google Scholar 

  47. McKenna WJ, Oakley CM, Krikler DM, Goodwin JF: Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J 1985, 53:412–416.

    PubMed  CAS  Google Scholar 

  48. Tendera M, Wycisk A, Schneeweiss A, et al.: Effect of sotalol on arrhythmias and exercise tolerance in patients with hypertrophic cardiomyopathy. Cardiology 1993, 82:335–342.

    Article  PubMed  CAS  Google Scholar 

  49. Savage DD, Seides SF, Maron BJ, et al.: Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation 1979, 59:866–875.

    PubMed  CAS  Google Scholar 

  50. McKenna WJ, England D, Doi YL, et al.: Arrhythmia in hypertrophic cardiomyopathy: I — Influence on prognosis. Br Heart J 1981, 46:168–172.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiologia S. Luca, Azienda Ospedaliera Careggi, Via Jacopo Nardi 30, 50132, Florence, Italy

    Iacopo Olivotto MD

  2. Minneapolis Heart Institute Foundation, 920 East 28th Street, Suite 40, 55407, Minneapolis, MN, USA

    Barry J. Maron MD

Authors
  1. Iacopo Olivotto MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barry J. Maron MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Franco Cecchi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Olivotto, I., Maron, B.J. & Cecchi, F. Clinical significance of atrial fibrillation in hypertrophic cardiomyopathy. Curr Cardiol Rep 3, 141–146 (2001). https://doi.org/10.1007/s11886-001-0041-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-001-0041-x

Keywords

Search

Navigation